Why the study?
Is lower eGFR associated with a higher prevalence of cognitive impairment in patients with chronic kidney disease?
Is lower eGFR associated with a higher prevalence of cognitive impairment in patients with chronic kidney disease?
Lower eGFR is associated with a higher prevalence of cognitive impairment in CKD, independent of traditional vascular risk factors, possibly mediated by anemia.
Supports cognitive screening consideration in low-eGFR CKD; leaves open anemia mediation and requires longitudinal confirmation.
The prevalence of cognitive impairment was higher among those with lower eGFR, independent of traditional vascular risk factors. This association may be explained in part by anemia.
No takes yet. Share an insight, caveat, or question.
Tamura et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: